Furthermore, in pancreatic carcinoma it has been related to resistance to radiotherapy and chemotherapy, since it is capable of activating the nuclear transcription factor NF-κβ, involved in proliferation and survival56. This evidence concerns the gene NFKB1 and exocrine pancreatic carcinoma.